RxDoctor Payments Data

James Vanharen, MD

Psychiatry · Grand Rapids, MINPI 1114901840

Payments from drug & device makers

$4,509in general payments, 2019–2025

Across 127 payments — averaging $35.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$3K
  • Otsuka America Pharmaceutical, Inc.$594
  • Teva Pharmaceuticals USA, Inc.$402
  • AbbVie$228
  • Supernus Pharmaceuticals, Inc.$214
  • Lundbeck LLC$131
  • plus $360 from 10 others

What the payments were for

  • Speaking & faculty fees$2,20849%
  • Food & beverage$2,07946%
  • Education$2235%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,509 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$4,410
Medicare patients
12
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide24$12,216
ClozarilClozapine13$10,676
Paliperidone ErPaliperidone27$8,065
RisperdalRisperidone12$4,818
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine40$1,553
Clozapine52$1,259
Divalproex Sodium ErDivalproex Sodium20$1,203
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$1,006
Aripiprazole15$966
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl11$868
Duloxetine Hcl44$851
Bupropion XlBupropion Hcl33$837
Sertraline Hcl31$813
Lamotrigine45$716
Buspirone Hcl39$588

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$45$12,21624 claims
Johnson & JohnsonRisperdal$81$4,81812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →